<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00634075</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-08-01</org_study_id>
    <nct_id>NCT00634075</nct_id>
  </id_info>
  <brief_title>Clinical Assessment of Fish Oil-based Lipid Emulsion Infusions in Critical Patients With Severe Sepsis</brief_title>
  <official_title>Clinical Assessment of Fish Oil-based Lipid Emulsion Infusions in Critical Patients With Severe Sepsis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Li Shin Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Li Shin Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether a fish oil-based lipid emulsion, enriched
      with ω-3 fatty acids, reduce proinflammatory cytokines and mortality rate in critically ill
      patients with severe sepsis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2008</start_date>
  <completion_date type="Actual">August 2009</completion_date>
  <primary_completion_date type="Actual">August 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>All cause mortality</measure>
    <time_frame>mortality rate on days 7 and 28.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lengths of ICU and hospital stay. Duration of mechanic ventilator requirement. Serial changing APACHE II and SOFA score. Changing of TNF-α, IL- 1β, IL-6, IL-8, and IL-10 levels. Incidence of hospital-acquired infection.</measure>
    <time_frame>Days 0, 1, 3, 5, 7, 14 and 28.</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Severe Sepsis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>omega-3-fatty acids (Omegaven)</intervention_name>
    <description>The enrolled patients will be randomized to receive either supplementation of fish oil-based lipid emulsion (10 % Omegaven) as group 1 or placebo (0.9% Normal Saline) as group 2 via a central venous catheter within 24 hours after ICU admission, 100 ml daily for 5 days, respectively.</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Omegaven</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>The enrolled patients will be randomized to receive either supplementation of fish oil-based lipid emulsion (10 % Omegaven) as group 1 or placebo (0.9% Normal Saline) as group 2 via a central venous catheter within 24 hours after ICU admission, 100 ml daily for 5 days, respectively.</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients admitted to Li Shin Hospital's ICU with a main diagnosis of severe sepsis.

        Exclusion Criteria:

          -  Age of ﹤15 years

          -  Pregnancy

          -  Patients treated with immunosuppressive drugs or the equivalent of hydrocortisone more
             than 300 mg daily

          -  Plasma triglyceride concentration of more than 400 mg/dl

          -  Infection with human immunodeficiency virus

          -  Anticipated rapid fatality from irreversible underlying disease or malignancy

          -  Severe hemorrhagic disorders

          -  Acute myocardial infarction

          -  Recent stroke (within 3 month)

          -  Suspected or proven pulmonary embolism

          -  Cirrhotic liver and/or acute hepatitis ( elevation of serum GOT or GPT &gt; 5 times of
             normal upper limit)

          -  Chronic renal failure (Cr &gt;3.5 mg/dl upon admission) or end stage of renal diseases

          -  Allergic reactions against fish or egg proteins.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Boon-Siang Khor, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Emergency &amp; Critical Care Medicine, Li Shin Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Li Shin Hospital</name>
      <address>
        <city>Pingjen</city>
        <state>Taoyuan County</state>
        <zip>32405</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>August 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 4, 2008</study_first_submitted>
  <study_first_submitted_qc>March 11, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 12, 2008</study_first_posted>
  <last_update_submitted>August 12, 2009</last_update_submitted>
  <last_update_submitted_qc>August 12, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 13, 2009</last_update_posted>
  <responsible_party>
    <name_title>Boon-Siang Khor</name_title>
    <organization>Department of Emergency &amp; Critical Care Medicine</organization>
  </responsible_party>
  <keyword>Severe sepsis</keyword>
  <keyword>Proinflammatory cytokines</keyword>
  <keyword>ICU</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

